000153759 001__ 153759
000153759 005__ 20251118111342.0
000153759 0247_ $$2doi$$a10.1038/s41467-020-14642-0
000153759 0247_ $$2pmid$$apmid:32071302
000153759 0247_ $$2altmetric$$aaltmetric:76251302
000153759 037__ $$aDKFZ-2020-00444
000153759 041__ $$aeng
000153759 082__ $$a500
000153759 1001_ $$0P:(DE-HGF)0$$aAslan, Katrin$$b0$$eFirst author
000153759 245__ $$aHeterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas.
000153759 260__ $$a[London]$$bNature Publishing Group UK$$c2020
000153759 3367_ $$2DRIVER$$aarticle
000153759 3367_ $$2DataCite$$aOutput Types/Journal article
000153759 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1763460810_1939188
000153759 3367_ $$2BibTeX$$aARTICLE
000153759 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000153759 3367_ $$00$$2EndNote$$aJournal Article
000153759 500__ $$a#EA:D170#LA:D170# / HI-TRON / #DKFZ-MOST-Ca188#
000153759 520__ $$aIntrinsic malignant brain tumors, such as glioblastomas are frequently resistant to immune checkpoint blockade (ICB) with few hypermutated glioblastomas showing response. Modeling patient-individual resistance is challenging due to the lack of predictive biomarkers and limited accessibility of tissue for serial biopsies. Here, we investigate resistance mechanisms to anti-PD-1 and anti-CTLA-4 therapy in syngeneic hypermutated experimental gliomas and show a clear dichotomy and acquired immune heterogeneity in ICB-responder and non-responder tumors. We made use of this dichotomy to establish a radiomic signature predicting tumor regression after pseudoprogression induced by ICB therapy based on serial magnetic resonance imaging. We provide evidence that macrophage-driven ICB resistance is established by CD4 T cell suppression and Treg expansion in the tumor microenvironment via the PD-L1/PD-1/CD80 axis. These findings uncover an unexpected heterogeneity of response to ICB in strictly syngeneic tumors and provide a rationale for targeting PD-L1-expressing tumor-associated macrophages to overcome resistance to ICB.
000153759 536__ $$0G:(DE-HGF)POF3-314$$a314 - Tumor immunology (POF3-314)$$cPOF3-314$$fPOF III$$x0
000153759 588__ $$aDataset connected to CrossRef, PubMed,
000153759 7001_ $$0P:(DE-He78)c0ce47b3ee5b2f0f349cddc8b7a44f5c$$aTurco, Verena$$b1$$udkfz
000153759 7001_ $$0P:(DE-He78)a9114d386dffd6b8746b19b19beed7d2$$aBlobner, Jens$$b2$$udkfz
000153759 7001_ $$0P:(DE-He78)1f1efec9a95d1778031cb6f0b19ba58b$$aSonner, Jana$$b3
000153759 7001_ $$aLiuzzi, Anna Rita$$b4
000153759 7001_ $$00000-0003-3837-270X$$aNúñez, Nicolás Gonzalo$$b5
000153759 7001_ $$aDe Feo, Donatella$$b6
000153759 7001_ $$aKickingereder, Philipp$$b7
000153759 7001_ $$0P:(DE-He78)0a8e3638e3c0deb4e5e49c72286a5b83$$aFischer, Manuel$$b8
000153759 7001_ $$0P:(DE-He78)9b97ca569bcb00dfda69382bc7261700$$aGreen, Ed$$b9$$udkfz
000153759 7001_ $$0P:(DE-He78)970bd627f415e0a127210d2cecf2311f$$aSadik, Ahmed$$b10$$udkfz
000153759 7001_ $$0P:(DE-He78)1cab354af0aff62f1b8d569477b4be4c$$aFriedrich, Mirco$$b11$$udkfz
000153759 7001_ $$0P:(DE-He78)ca9f3aa4fcee93af10f7e792516e7193$$aSanghvi, Khwab$$b12$$udkfz
000153759 7001_ $$0P:(DE-He78)bed62b0b74cf1048663fbefeb4b5d7bc$$aKilian, Michael$$b13$$udkfz
000153759 7001_ $$0P:(DE-He78)7c69c3cf30a54f9f06e15af48f62ce3c$$aCichon, Frederik$$b14$$udkfz
000153759 7001_ $$0P:(DE-He78)ff32a4dc9676ae1685490c42e75bdb35$$aWolf, Lara$$b15
000153759 7001_ $$0P:(DE-He78)106aed16a97ff393cca5528582f8c655$$aJähne, Kristine$$b16$$udkfz
000153759 7001_ $$0P:(DE-He78)e33cce63a8732306894f1135dca8e119$$avon Landenberg, Anna$$b17
000153759 7001_ $$0P:(DE-He78)e579130c57e8c686ed1c2dedfa595985$$aBunse, Lukas$$b18$$udkfz
000153759 7001_ $$0P:(DE-He78)a1f4b408b9155beb2a8f7cba4d04fe88$$aSahm, Felix$$b19$$udkfz
000153759 7001_ $$0P:(DE-He78)e54a1e0999c1d8c95869ef9188b794cc$$aSchrimpf, Daniel$$b20$$udkfz
000153759 7001_ $$0P:(DE-He78)b6273c0ba3ae37a4d3d1c6b084797f2e$$aMeyer, Jochen$$b21$$udkfz
000153759 7001_ $$0P:(DE-HGF)0$$aAlexander, Allen$$b22
000153759 7001_ $$00000-0003-2461-1407$$aBrugnara, Gianluca$$b23
000153759 7001_ $$aRöth, Ralph$$b24
000153759 7001_ $$0P:(DE-He78)a918fd124837fc8de5f4a45ade9a007a$$aPfleiderer, Kira$$b25$$udkfz
000153759 7001_ $$00000-0001-7881-6112$$aNiesler, Beate$$b26
000153759 7001_ $$0P:(DE-He78)a8a10626a848d31e70cfd96a133cc144$$avon Deimling, Andreas$$b27$$udkfz
000153759 7001_ $$0P:(DE-He78)14aa02d2ca0515d0c53f1d6678e3ca34$$aOpitz, Christiane$$b28$$udkfz
000153759 7001_ $$0P:(DE-He78)5ba5b48bd126214d9cb66291fa4ae303$$aBreckwoldt, Michael$$b29$$udkfz
000153759 7001_ $$aHeiland, Sabine$$b30
000153759 7001_ $$aBendszus, Martin$$b31
000153759 7001_ $$0P:(DE-He78)92e9783ca7025f36ce14e12cd348d2ee$$aWick, Wolfgang$$b32$$udkfz
000153759 7001_ $$00000-0002-1541-7867$$aBecher, Burkhard$$b33
000153759 7001_ $$0P:(DE-He78)5ef8651b0f857b9c640aa5b1498c43b5$$aPlatten, Michael$$b34$$eLast author$$udkfz
000153759 773__ $$0PERI:(DE-600)2553671-0$$a10.1038/s41467-020-14642-0$$gVol. 11, no. 1, p. 931$$n1$$p931$$tNature Communications$$v11$$x2041-1723$$y2020
000153759 909CO $$ooai:inrepo02.dkfz.de:153759$$pVDB
000153759 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000153759 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)c0ce47b3ee5b2f0f349cddc8b7a44f5c$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000153759 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a9114d386dffd6b8746b19b19beed7d2$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000153759 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)1f1efec9a95d1778031cb6f0b19ba58b$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000153759 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)0a8e3638e3c0deb4e5e49c72286a5b83$$aDeutsches Krebsforschungszentrum$$b8$$kDKFZ
000153759 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)9b97ca569bcb00dfda69382bc7261700$$aDeutsches Krebsforschungszentrum$$b9$$kDKFZ
000153759 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)970bd627f415e0a127210d2cecf2311f$$aDeutsches Krebsforschungszentrum$$b10$$kDKFZ
000153759 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)1cab354af0aff62f1b8d569477b4be4c$$aDeutsches Krebsforschungszentrum$$b11$$kDKFZ
000153759 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)ca9f3aa4fcee93af10f7e792516e7193$$aDeutsches Krebsforschungszentrum$$b12$$kDKFZ
000153759 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)bed62b0b74cf1048663fbefeb4b5d7bc$$aDeutsches Krebsforschungszentrum$$b13$$kDKFZ
000153759 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)7c69c3cf30a54f9f06e15af48f62ce3c$$aDeutsches Krebsforschungszentrum$$b14$$kDKFZ
000153759 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)ff32a4dc9676ae1685490c42e75bdb35$$aDeutsches Krebsforschungszentrum$$b15$$kDKFZ
000153759 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)106aed16a97ff393cca5528582f8c655$$aDeutsches Krebsforschungszentrum$$b16$$kDKFZ
000153759 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)e33cce63a8732306894f1135dca8e119$$aDeutsches Krebsforschungszentrum$$b17$$kDKFZ
000153759 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)e579130c57e8c686ed1c2dedfa595985$$aDeutsches Krebsforschungszentrum$$b18$$kDKFZ
000153759 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a1f4b408b9155beb2a8f7cba4d04fe88$$aDeutsches Krebsforschungszentrum$$b19$$kDKFZ
000153759 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)e54a1e0999c1d8c95869ef9188b794cc$$aDeutsches Krebsforschungszentrum$$b20$$kDKFZ
000153759 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)b6273c0ba3ae37a4d3d1c6b084797f2e$$aDeutsches Krebsforschungszentrum$$b21$$kDKFZ
000153759 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b22$$kDKFZ
000153759 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a918fd124837fc8de5f4a45ade9a007a$$aDeutsches Krebsforschungszentrum$$b25$$kDKFZ
000153759 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a8a10626a848d31e70cfd96a133cc144$$aDeutsches Krebsforschungszentrum$$b27$$kDKFZ
000153759 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)14aa02d2ca0515d0c53f1d6678e3ca34$$aDeutsches Krebsforschungszentrum$$b28$$kDKFZ
000153759 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)5ba5b48bd126214d9cb66291fa4ae303$$aDeutsches Krebsforschungszentrum$$b29$$kDKFZ
000153759 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)92e9783ca7025f36ce14e12cd348d2ee$$aDeutsches Krebsforschungszentrum$$b32$$kDKFZ
000153759 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)5ef8651b0f857b9c640aa5b1498c43b5$$aDeutsches Krebsforschungszentrum$$b34$$kDKFZ
000153759 9131_ $$0G:(DE-HGF)POF3-314$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vTumor immunology$$x0
000153759 9141_ $$y2020
000153759 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNAT COMMUN : 2017
000153759 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000153759 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000153759 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000153759 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central
000153759 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal
000153759 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ
000153759 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review
000153759 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ
000153759 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000153759 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000153759 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000153759 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000153759 915__ $$0StatID:(DE-HGF)1060$$2StatID$$aDBCoverage$$bCurrent Contents - Agriculture, Biology and Environmental Sciences
000153759 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000153759 915__ $$0StatID:(DE-HGF)1150$$2StatID$$aDBCoverage$$bCurrent Contents - Physical, Chemical and Earth Sciences
000153759 915__ $$0StatID:(DE-HGF)1040$$2StatID$$aDBCoverage$$bZoological Record
000153759 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000153759 915__ $$0StatID:(DE-HGF)9910$$2StatID$$aIF >= 10$$bNAT COMMUN : 2017
000153759 9202_ $$0I:(DE-He78)D170-20160331$$kD170$$lKKE Neuroimmunologie und Hirntumorimmunologie$$x0
000153759 9201_ $$0I:(DE-He78)D170-20160331$$kD170$$lKKE Neuroimmunologie und Hirntumorimmunologie$$x0
000153759 9201_ $$0I:(DE-He78)B350-20160331$$kB350$$lMetabolischer Crosstalk bei Krebserkrankungen$$x1
000153759 9201_ $$0I:(DE-He78)B300-20160331$$kB300$$lKKE Neuropathologie$$x2
000153759 9201_ $$0I:(DE-He78)B320-20160331$$kB320$$lKKE Neuroonkologie$$x3
000153759 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x4
000153759 9200_ $$0I:(DE-He78)D170-20160331$$kD170$$lKKE Neuroimmunologie und Hirntumorimmunologie$$x0
000153759 980__ $$ajournal
000153759 980__ $$aVDB
000153759 980__ $$aI:(DE-He78)D170-20160331
000153759 980__ $$aI:(DE-He78)B350-20160331
000153759 980__ $$aI:(DE-He78)B300-20160331
000153759 980__ $$aI:(DE-He78)B320-20160331
000153759 980__ $$aI:(DE-He78)HD01-20160331
000153759 980__ $$aUNRESTRICTED